Like OCT4 and SOX2, NANOG can promote cell survival, anti-apoptotic signaling, migration, invasion, and chemoresistance, and is overexpressed in various cancers, including breast, ovarian, melanoma, and others 31. Here, SOX2 is linked to cancer.